BioNTech

Global race to recover from Covid-19 - THE EDGE SINGAPORE

Tong's Portfolio

Global race to recover from Covid-19

Last Tuesday, the UK became the first major Western country to start inoculating its population.
Small is better for vaccine shares - THE EDGE SINGAPORE

Covid-19

Small is better for vaccine shares

Big vaccine news makes little difference to pharma giant shares.
Global economic recovery will be stronger than expected - THE EDGE SINGAPORE

Tong's Portfolio

Global economic recovery will be stronger than expected

Amid all the grim Covid-19 headlines, stock prices have continued to move higher.
Pfizer, BioNTech plan filing as vaccine proves 95% effective - THE EDGE SINGAPORE

Covid-19

Pfizer, BioNTech plan filing as vaccine proves 95% effective

A third contender, from AstraZeneca and the University of Oxford, is expected to release trial results in the coming days.
Analysts mixed on SATS despite potential Covid-19 vaccine, air travel bubble - THE EDGE SINGAPORE

Broker's Calls

Analysts mixed on SATS despite potential Covid-19 vaccine, air travel bubble

DBS Group Research reckons that a recovery to pre-Covid-19 levels for international air travel could occur in 2022.
SIA gets a lift from potential Covid vaccine and travel bubble but recovery still nascent - THE EDGE SINGAPORE

Company in the news

SIA gets a lift from potential Covid vaccine and travel bubble but recovery still nascent

SIA says it is encouraged by the development of Pfizer’s experimental Covid-19 vaccine.

Covid-19

Is a viable Covid-19 vaccine imminent?

Dr Mike Ryan, head of WHO’s emergencies program maintains that there is still a long way to go before a vaccine can be rolled out.
  •  
×